IL153740A0 - Grf2-binding proteins and applications thereof - Google Patents

Grf2-binding proteins and applications thereof

Info

Publication number
IL153740A0
IL153740A0 IL15374001A IL15374001A IL153740A0 IL 153740 A0 IL153740 A0 IL 153740A0 IL 15374001 A IL15374001 A IL 15374001A IL 15374001 A IL15374001 A IL 15374001A IL 153740 A0 IL153740 A0 IL 153740A0
Authority
IL
Israel
Prior art keywords
grf2
applications
binding proteins
proteins
binding
Prior art date
Application number
IL15374001A
Other languages
English (en)
Original Assignee
Mds Proteomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mds Proteomics Inc filed Critical Mds Proteomics Inc
Publication of IL153740A0 publication Critical patent/IL153740A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
IL15374001A 2000-06-30 2001-06-29 Grf2-binding proteins and applications thereof IL153740A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21550400P 2000-06-30 2000-06-30
US26369001P 2001-01-24 2001-01-24
PCT/CA2001/000941 WO2002002629A2 (en) 2000-06-30 2001-06-29 Grf2-binding proteins and applications thereof

Publications (1)

Publication Number Publication Date
IL153740A0 true IL153740A0 (en) 2003-07-06

Family

ID=26910105

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15374001A IL153740A0 (en) 2000-06-30 2001-06-29 Grf2-binding proteins and applications thereof

Country Status (7)

Country Link
US (1) US20040170969A1 (ja)
EP (1) EP1299534A2 (ja)
JP (1) JP2004501670A (ja)
AU (1) AU2001267242A1 (ja)
CA (1) CA2413715A1 (ja)
IL (1) IL153740A0 (ja)
WO (1) WO2002002629A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933127B2 (en) 2001-07-05 2005-08-23 Eucro European Contract Research Gmbh & Co. Kg Substrate for PP2C
JP2004018524A (ja) * 2002-06-13 2004-01-22 Eucro European Contract Research Gmbh & Co Kg 動脈硬化症を処置するための方法
EP1717320A1 (en) * 2005-04-26 2006-11-02 TopoTarget Germany AG Identification of human gene sequences of cancer antigens expressed in metastatic carcinoma and involved in metastasis formation, and their use in cancer diagnosis, prognosis and therapy
WO2019158911A1 (en) * 2018-02-14 2019-08-22 Institute Of Genetics And Developmental Biology Chinese Academy Of Sciences Methods of increasing nutrient use efficiency

Also Published As

Publication number Publication date
US20040170969A1 (en) 2004-09-02
EP1299534A2 (en) 2003-04-09
JP2004501670A (ja) 2004-01-22
WO2002002629A3 (en) 2002-09-06
CA2413715A1 (en) 2002-01-10
AU2001267242A1 (en) 2002-01-14
WO2002002629A2 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
AU9667901A (en) Mycoattractants and mycopesticides
EP1463742A4 (en) NEW PYRAZOLO AND PYRROLO PYRIMIDINES AND THEIR USES
EP1408978A4 (en) NOVEL PHENYLAMINO-PYRIMIDINES AND THEIR USE
AU4196801A (en) Chordin-like-2 molecules and uses thereof
IL154553A0 (en) Urocortin-iii and uses thereof
EP1414848A4 (en) REPLICINE PEPTIDES AND ITS USES
EP1419175A4 (en) PEPTIDES OF REPLIKIN AND THEIR USE
EP1357186A4 (en) NEW PROTEINS AND CORRESPONDING DNA
AU2002211220A1 (en) Secreted proteins and their uses
EP1293568A4 (en) PROTEIN AND ITS DNA
EP1408985A4 (en) NEW PYRIDOPYRIMIDONE AND ITS USES
EP1302770A4 (en) PARTICLE MARKING PROTEIN AND IMMUNO-CHROMATOGRAPHER USING THE SAME
GB0026134D0 (en) Peptides and their use
AU2001290551A1 (en) Secreted proteins and their uses
IL153740A0 (en) Grf2-binding proteins and applications thereof
GB0020952D0 (en) Genes and proteins and their uses
EP1337543A4 (en) STREPTAVIDINE-BINDING PEPTIDES AND USES THEREOF
EP1293510A4 (en) POLYPEPTIDE AND ITS DNA
GB0102447D0 (en) Protein variants and uses thereof
GB0019503D0 (en) Proteins and their uses
AU2001250047A1 (en) Effector-specific protein assembly and uses thereof
HUP0300489A3 (en) Novel protein and gene encoding the same
EP1395276A4 (en) STRUCTURALLY MODIFIED PEPTIDES AND THEIR USE
EP1179592A4 (en) NECTIN-3 PROTEINS